SORAVE: Sorafenib and everolimus for patients with solid tumors and with KRAS mutated NSCLC - results of a phase I study

Authors
Publication date
1 January 2014
Publisher
'S. Karger AG'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:4...
    Last time updated on 08/04/2021